Skip to Content

ER 0.375 (Mirapex ER 0.375 mg)

Generic Name: pramipexole

Pill imprint ER 0.375 has been identified as Mirapex ER 0.375 mg.

Mirapex ER is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Mirapex ER 0.375 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mirapex ER 0.375 mg ER 0.375
Mirapex ER 0.375 mg ER 0.375
Mirapex ER 0.375 mg ER 0.375
Mirapex ER
Generic Name:
pramipexole
Imprint:
ER 0.375
Strength:
0.375 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Boehringer Ingelheim Pharmaceuticals, Inc.
National Drug Code (NDC):
00597-0109

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide